You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)

Citation Tools

Article menu
Original research
Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Achtnichts L, Zecca C, Findling O, et al
Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)
BMJ Neurology Open 2023;5:e000304. doi: 10.1136/bmjno-2022-000304